SEC Form 4 · accession 0001999086-26-000021
CLOVER HEALTH INVESTMENTS, CORP. /DE · CLOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Soares
Officer — Chief Legal Officer
Period of report
Jul 20, 2026
Accepted (ET)
Jul 20, 2026 · 5:48 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001801170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Jul 20, 2026 | S | 51,700 | $4.51 | D | 1,505,522 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 13, 2026.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.